Already-Rich Startup, Juno Therapeutics, Expands Series A Funding Round To $145 Million
1/14/2014 7:39:08 AM
Seattle-based Juno Therapeutics is already one of the richest biotech startups in industry history, and today it got even richer. The company said today it expanded its Series A venture financing to the jaw-dropping sum of $145 million. Bezos Expeditions, the investment vehicle for Amazon billionaire Jeff Bezos, joined the round, along with Venrock.
Help employers find you! Check out all the jobs and post your resume.
comments powered by